This is despite it being legal to prescribe and produce compounded medications during drug shortages or when medically necessary
No, AOD-9604 is not FDA-approved for human therapeutic use
A responsible plan may include adequate protein intake, resistance training, walking or other appropriate activity, body composition tracking when available, lab monitoring, gradual dose escalation when appropriate, nutrition support during appetite reduction, hydration and electrolyte guidance, monitoring fatigue or excessive appetite suppression, and evaluation for hormone, thyroid, or nutrient issues when relevant
No dose-limiting toxicities were observed at any tested dose
Tirzepatide achieves superior weight loss compared to semaglutide despite both being GLP-1 agonists